Ensign Peak Advisors’s OrthoPediatrics KIDS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-71,803
Closed -$4.3M 2231
2021
Q4
$4.3M Buy
71,803
+46,848
+188% +$2.92M 0.01% 710
2021
Q3
$1.64M Buy
24,955
+4,703
+23% +$305K ﹤0.01% 1224
2021
Q2
$1.28M Hold
20,252
﹤0.01% 1347
2021
Q1
$987K Sell
20,252
-2,962
-13% -$142K ﹤0.01% 1430
2020
Q4
$958K Sell
23,214
-73
-0.3% -$3.35K ﹤0.01% 1416
2020
Q3
$1.07M Sell
23,287
-13,638
-37% -$633K ﹤0.01% 1286
2020
Q2
$1.62M Hold
36,925
﹤0.01% 1085
2020
Q1
$1.46M Sell
36,925
-5,652
-13% -$253K ﹤0.01% 981
2019
Q4
$2M Buy
+42,577
New +$1.65M 0.01% 1060

Other funds holding KIDS

Ensign Peak Advisors's KIDS Position: Q1 2022 in Review

Ensign Peak Advisors sold out of OrthoPediatrics (KIDS) in Q1 2022, closing a stake of 71,803 shares — an estimated $4.3M sold.

Ensign Peak Advisors first reported a position in KIDS in Q4 2019 and held it in 9 quarters. The position peaked at $4.3M in Q4 2021. 127 funds tracked by Wall St. Rank hold KIDS as of Q1 2022.

  • Ensign Peak Advisors reported no remaining OrthoPediatrics position as of Q1 2022 after selling out during the quarter.
  • Ensign Peak Advisors sold 71,803 OrthoPediatrics shares in Q1 2022, an estimated $4.3M.
  • Ensign Peak Advisors first reported a position in OrthoPediatrics in Q4 2019 and held it in 9 quarters.
  • Ensign Peak Advisors's OrthoPediatrics position peaked at $4.3M in Q4 2021.
  • 127 funds tracked by Wall St. Rank held OrthoPediatrics as of Q1 2022.

Based on Ensign Peak Advisors's 13F filing for Q1 2022, filed 16 May 2022.